Literature DB >> 22266197

SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β.

Brenda J Mengeling1, Michael L Goodson, William Bourguet, Martin L Privalsky.   

Abstract

The SMRT and NCoR corepressors bind to, and mediate transcriptional repression by, many nuclear receptors. Both SMRT and NCoR are expressed by alternative mRNA splicing, generating a series of structurally and functionally distinct corepressor "variants". We report that a splice variant of SMRT, SMRTε, recognizes a restricted subset of nuclear receptors. Unlike the other corepressor variants characterized, SMRTε possesses only a single receptor interaction domain (RID) and exhibits an unusual specificity for a subset of nuclear receptors that includes the retinoic acid receptors (RARs). The ability of the single RID in SMRTε to efficiently interact with RARs appears to be enhanced by a recently recognized β-strand/β-strand interaction between corepressor and receptor. We suggest that alternative mRNA splicing of corepressors can restrict their function to specific nuclear receptor partnerships, and we propose that this may serve to customize the transcriptional repression properties of different cell types for different biological purposes. Copyright Â
© 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266197      PMCID: PMC3288673          DOI: 10.1016/j.mce.2012.01.006

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  74 in total

Review 1.  DNA recognition by nuclear receptors.

Authors:  Frank Claessens; Daniel T Gewirth
Journal:  Essays Biochem       Date:  2004       Impact factor: 8.000

Review 2.  International Union of Pharmacology. LXVI. Orphan nuclear receptors.

Authors:  Gérard Benoit; Austin Cooney; Vincent Giguere; Holly Ingraham; Mitch Lazar; George Muscat; Thomas Perlmann; Jean-Paul Renaud; John Schwabe; Frances Sladek; Ming-Jer Tsai; Vincent Laudet
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

Review 3.  International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors.

Authors:  Frédéric Flamant; John D Baxter; Douglas Forrest; Samuel Refetoff; Herbert Samuels; Tom S Scanlan; Bjorn Vennström; Jacques Samarut
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

Review 4.  Nuclear receptors: one big family.

Authors:  Iain J McEwan
Journal:  Methods Mol Biol       Date:  2009

5.  A novel role for helix 12 of retinoid X receptor in regulating repression.

Authors:  J Zhang; X Hu; M A Lazar
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

6.  Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors.

Authors:  S Sande; M L Privalsky
Journal:  Mol Endocrinol       Date:  1996-07

7.  Structure of Rev-erbalpha bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interaction.

Authors:  Caroline A Phelan; Robert T Gampe; Millard H Lambert; Derek J Parks; Valerie Montana; Jane Bynum; Timothy M Broderick; Xiao Hu; Shawn P Williams; Robert T Nolte; Mitchell A Lazar
Journal:  Nat Struct Mol Biol       Date:  2010-06-27       Impact factor: 15.369

8.  Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.

Authors:  L Nagy; H Y Kao; D Chakravarti; R J Lin; C A Hassig; D E Ayer; S L Schreiber; R M Evans
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

Review 9.  Deconstructing repression: evolving models of co-repressor action.

Authors:  Valentina Perissi; Kristen Jepsen; Christopher K Glass; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2010-02       Impact factor: 53.242

10.  Unexpected novel relational links uncovered by extensive developmental profiling of nuclear receptor expression.

Authors:  Stéphanie Bertrand; Bernard Thisse; Raquel Tavares; Laurent Sachs; Arnaud Chaumot; Pierre-Luc Bardet; Héctor Escrivà; Maryline Duffraisse; Oriane Marchand; Rachid Safi; Christine Thisse; Vincent Laudet
Journal:  PLoS Genet       Date:  2007-11       Impact factor: 5.917

View more
  10 in total

1.  Alteration of NCoR corepressor splicing in mice causes increased body weight and hepatosteatosis without glucose intolerance.

Authors:  Michael L Goodson; Briana M Young; Chelsea A Snyder; Amy C Schroeder; Martin L Privalsky
Journal:  Mol Cell Biol       Date:  2014-09-02       Impact factor: 4.272

Review 2.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

3.  Pan-cancer analyses of the nuclear receptor superfamily.

Authors:  Mark D Long; Moray J Campbell
Journal:  Nucl Receptor Res       Date:  2015-12-15

Review 4.  Thyroid hormone regulation of metabolism.

Authors:  Rashmi Mullur; Yan-Yun Liu; Gregory A Brent
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

5.  Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity.

Authors:  Mark D Long; Patrick R van den Berg; James L Russell; Prashant K Singh; Sebastiano Battaglia; Moray J Campbell
Journal:  Nucleic Acids Res       Date:  2015-06-27       Impact factor: 16.971

6.  Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis.

Authors:  Almudena Bosch; Silvina P Bertran; Yongke Lu; Avalon Garcia; Alexis M Jones; Marcia I Dawson; Eduardo F Farias
Journal:  Breast Cancer Res       Date:  2012-08-24       Impact factor: 6.466

Review 7.  Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.

Authors:  Prashant K Singh; Craig L Doig; Vineet K Dhiman; Bryan M Turner; Dominic J Smiraglia; Moray J Campbell
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-23       Impact factor: 4.292

8.  Corepressor diversification by alternative mRNA splicing is species specific.

Authors:  Martin L Privalsky; Chelsea A Snyder; Michael L Goodson
Journal:  BMC Evol Biol       Date:  2016-10-19       Impact factor: 3.260

9.  Specific ablation of the NCoR corepressor δ splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism.

Authors:  Michael L Goodson; Trina A Knotts; Elsie L Campbell; Chelsea A Snyder; Briana M Young; Martin L Privalsky
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

10.  Short linear motif acquisition, exon formation and alternative splicing determine a pathway to diversity for NCoR-family co-repressors.

Authors:  Stephen Short; Tessa Peterkin; Matthew Guille; Roger Patient; Colin Sharpe
Journal:  Open Biol       Date:  2015-08       Impact factor: 6.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.